Ilya Shpurov
Chairman of the board of directors
Ilya Shpurov, as Chairman of the Board of Directors at Noya Therapeutics, brings a wealth of experience spanning over three decades in both the pharmaceutical and technology sectors.
His entrepreneurial journey began in 1990 with the founding of Mori trade company, leading to a series of ventures including the innovative Middle Computer Technologies. His strategic vision led to the acquisition and modernization of Kraspharma, a leading pharmaceutical company, and work with Bebig, a pioneer in low-dose brachytherapy for cancer treatment.
In 2019, he established Nanokaskad, focusing on high-tech medical equipment for blood plasma filtration, and orchestrated the merger of his pharmaceutical ventures into a formidable holding.
His leadership was further solidified in 2020 when he took the helm at Noya, steering the company towards groundbreaking advancements in nuclear medicine and pharmaceutical technology. Ilya Shpurov’s contributions to the industry are marked by a continuous investment in research and development, underpinning his commitment to science.
